Hims & Hers Health, Inc. Net Income Soars 219.55% on Strong Q2 2025 Results

Hims & Hers Health, Inc. reported strong financial results for Q2 2025, surpassing analyst expectations. The company announced revenue of $544.8 million, marking a 73% increase year-over-year from Q2 2024's $315.6 million. Net income reached $42.5 million, a significant rise from $13.3 million in the prior year period, representing a 219.55% year-over-year change. The reported revenue of $544.8 million exceeded the analyst estimate of $552.05 million, while the net income of $42.5 million, when converted to EPS (0.17 diluted EPS from the filing), also surpassed the analyst EPS estimate of $0.18.

Key Business Drivers

The company's performance was significantly bolstered by a robust growth in subscribers, which increased by 31% year-over-year to over 2.4 million in Q2 2025. Online Revenue, the primary contributor, surged by 75% to $536.88 million, driven by increased subscriber engagement and a 30% rise in Monthly Online Revenue per Average Subscriber to $74. This highlights the effectiveness of personalized treatment plans and the company's direct-to-consumer model.

Management Outlook

Management expressed confidence in their business model, emphasizing their focus on expanding into new, high-impact specialties to bring more individuals into the healthcare market. They anticipate transforming their platform from a single-issue solution to a comprehensive health management tool. CFO Yemi Okupe highlighted plans for continued investment in personalization infrastructure within pharmacies, expansion of lab testing capabilities for tailored care, and growth of international presence in key markets.

Financial Guidance

For the third quarter of 2025, Hims & Hers expects revenue to range between $570 million and $590 million, with Adjusted EBITDA projected to be between $60 million and $70 million. The company affirmed its full-year 2025 revenue guidance of $2.3 billion to $2.4 billion and Adjusted EBITDA guidance of $295 million to $335 million, reflecting anticipated continued growth and profitability.